权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Metabolic adaptions of Mycobacterium tuberculosis at diverse host-pathogen interfaces

结核分枝杆菌在不同宿主-病原体界面的代谢适应

基本信息

批准号：
10630740
负责人：
DAVID Branch MOODY
金额：
$ 54.38万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-07-01 至 2026-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10630740
关键词：
Animal Model Antitubercular Agents Bacterial Genes CRISPR interference CRISPR library Disease Disease Outcome Drug Targeting Encapsulated Epithelial Essential Genes Funding Genes Genetic Genetic Variation Genome Mappings Genotype Grant Granuloma Growth House mice Human Inbred Mouse Inbred Strain Inbred Strains Mice Individual Infection Integration Host Factors Lesion Libraries Link Lipids Measures Metabolic Metabolism Modeling Mosaicism Mouse Strains Mus Mycobacterium tuberculosis Nucleotides Outcome Parents Phenotype Population Pre-Clinical Model Process Quantitative Trait Loci Recombinants Reproducibility Resolution Resources Shapes Site System Technology Tuberculosis Variant Virulence Work bacterial genetics base cohort disease diagnostic genome wide association study genome-wide genomic locus human disease improved in vivo mammalian genome mouse model mutant novel parent grant pathogen reference genome response stem trait transposon sequencing tuberculosis treatment

项目摘要

Metabolic adaptions of Mycobacterium tuberculosis at diverse host-pathogen interfaces ABSTRACT Defining the mechanisms through which Mycobacterium tuberculosis (Mtb) metabolites impact human tuberculosis (TB) disease, diagnostics and treatment will require the implementation of model animal systems that are both tractable and faithfully replicate the TB disease states observed in humans. To overcome the limited genetic and phenotypic diversity shown in standard C57BL/6J, here we propose to leverage the comprehensive panel of Collaborative Cross (CC) mice, a genetically diverse panel of recombinant inbred mice. We have previously shown that the CC encompasses a broad spectrum of TB disease traits and infection microenvironments, exceeding the phenotypic spectrum observed in classical inbred strains. Based on previous TnSeq studies and as part of the parent TBRU grant (“Metabolic determinants of Mtb virulence, vulnerability and variation”; 1U19AI162584-02), we have ranked Mtb metabolic genes that were linked to Mtb virulence or control lipid variation in Mtb strains that infect humans. Of 19 high value Mtb metabolic genes identified, only one controlled growth in the conventional C57BL/6J (BL6) mouse strain. However, more than half the mutants studied showed in vivo growth phenotypes when screened across CC mouse strains. Further, through study of several of the CC host genetic backgrounds in which individual bacterial genes do or do not control in vivo Mtb survival, we are able to start to define the host factors in control of Mtb response. The current application will now extend these studies to focus on a targeted bacterial lipid library of CRISPRi mutants in conjunction with the comprehensive panel of CC mice. By infecting 60 distinct CC genotypes with the targeted lipid CRISPRi library, the metabolic vulnerabilities of Mtb will be comprehensively defined in genetically diverse hosts. By using bacterial mutant abundance as a phenotypic trait, we will conduct quantitative trait loci (QTL) mapping across the CC panel to identify the host loci underlying the lipid requirements of Mtb infection. Altogether these dual host and pathogen approaches will identify the host-Mtb lipid interactions that can be targeted for tuberculosis treatment.

结核分枝杆菌在不同宿主-病原体界面上的代谢适应